首页(Home)
品牌专区(Brands-parters)
//自动完成提示
function beginSearch() {
if (document.getElementById("Keyword").value.replace(/(^\s*)|(\s*$)/g, "").length > 2) {
$("#divMsg").html("");
var tbSearch = document.getElementById("Keyword").value;
var div_msg = document.getElementById("divMsg");
div_msg.style.display = "block";
$.ajax({
type: "post",
dataType: "json", //数据格式:JSON
url: "/tools/submit_ajax.ashx?action=zhitishi",
data: { father: tbSearch },
async: false,
success: function (data) {
var str = "";
var str1 = "";
var str2 = "";
var str3 = "";
var SupplyType = data.SupplyType; //供应品类列表
var Brands = data.Brands; //品牌列表
var ProductStyle = data.ProductStyle; //产品列表
var str0 = "";
if (SupplyType != null && SupplyType != "") {
str0 += " DxNA www.dxna.com Following the FDA requirements for the manufacturing of medical devices, the company has successfully completed the design and development phase as well as the internal verification of the GeneSTAT platform. DxNA is fully compliant with the Quality System Regulations, has achieved ISO 13485:2003 certification, and has also received notice of the GeneSTAT® analyzer CE mark registration. DxNA does the final assembly and calibration of the GeneSTAT® analyzer in-house and manufactures the test cartridge assays at its St. George Utah facility. We are now focused on obtaining FDA 510(k) clearance for the GeneSTAT® analyzer and accompanying assay test cartridges. History供应分类";
$.each(SupplyType, function () {//遍历Specification
str0 += "";
});
}
if (ProductStyle != null && ProductStyle != "") {
str1 += "产品分类";
$.each(ProductStyle, function () {//遍历ProductType
str1 += "";
});
}
if (Brands != null && Brands != "") {
str2 = "品牌";
$.each(Brands, function () {//遍历Brands
str2 += "";
});
}
str = str0 + str2 + "";
$("#divMsg").html(str);
}
});
}
else if (document.getElementById("Keyword").value.replace(/(^\s*)|(\s*$)/g, "").length == 0) {
var div_msg = document.getElementById("divMsg");
div_msg.style.display = "none";
div_msg.innerHTML = "";
}
}
分子诊断公司
DxNA, llc., is a molecular diagnostic company that focuses on simple, rapid and affordable real time PCR technology for users such as clinics, small to medium sized hospitals, doctors’ offices, and others with a need for low throughput or portable PCR diagnostics. To fulfill this objective, DxNA has successfully developed its GeneSTAT® analyzer and its multiplexed test cartridge system. Patents have already been secured for the analyzer, and patents are pending for the proprietary test cartridge. Validation studies were successfully completed by independent laboratories comparing GeneSTAT® assays for 2009 A/H1N1 Influenza and 2010 A/H5N1 influenza. These studies showed the GeneSTAT® system to be comparable in both sensitivity and specificity to the “gold standard” of high throughput lab based PCR systems.
DxNA, LLC., was established in 2008 as the successor company of Dx Nucleic Analytics, LLC., which was founded in 2005. The Company developed, manufactures, and markets a proprietary Real Time - PCR molecular diagnostic platform under the trademark GeneSTAT®. The platform is comprised of an analyzer and single-use test cartridge.
